On the other hand, two studies described the anti-tumor activity of CD26 high-CD4+ T cells, but it is currently unclear whether, how, or at which stage DPP-IV/CD26 may play a role in the development of this T-cell subpopulation [154,155]. This evidence concerns the gene CD4 and neoplasm.